Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Patients Co-Infected with HCV and HIV-1: The Phase 3 Astral-5 Study

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Wyles, D; Brau, N; Kottilil, S; Daar, E; Workowski, K; Luetkemeyer, A; Adeyemi, O; Ruane, P; Doehle, B; Huang, K; Osinusi, A; McNally, J; Brainard, D; McHutchison, J; Naggie, S; Sulkowski, M

Published Date

  • 2016

Published In

Volume / Issue

  • 64 / 2

Start / End Page

  • S188 - S189

International Standard Serial Number (ISSN)

  • 0168-8278

Digital Object Identifier (DOI)

  • 10.1016/S0168-8278(16)00129-X